269 related articles for article (PubMed ID: 21455110)
21. Interleukin-26 is overexpressed in Behçet's disease and enhances Th17 related -cytokines.
Kaabachi W; Bouali E; Berraïes A; Dhifallh IB; Hamdi B; Hamzaoui K; Hamzaoui A
Immunol Lett; 2017 Oct; 190():177-184. PubMed ID: 28811236
[TBL] [Abstract][Full Text] [Related]
22. Increased peripheral RORα and RORγt mRNA expression is associated with acute-on-chronic hepatitis B liver failure.
Qi ZX; Wang LY; Fan YC; Zhang JJ; Li T; Wang K
J Viral Hepat; 2012 Nov; 19(11):811-22. PubMed ID: 23043388
[TBL] [Abstract][Full Text] [Related]
23. Interleukin-17 mRNA expression and serum levels in Behçet's disease.
Jadideslam G; Kahroba H; Ansarin K; Sakhinia E; Abhar A; Alipour S; Farhadi J; Seydi Shirvani S; Nouri-Vaskeh M; Mousavi S; Khabbazi A
Cytokine; 2020 Mar; 127():154994. PubMed ID: 31951967
[TBL] [Abstract][Full Text] [Related]
24. Interleukin-37 expression is decreased in Behçet's disease and is associated with inflammation.
Bouali E; Kaabachi W; Hamzaoui A; Hamzaoui K
Immunol Lett; 2015 Oct; 167(2):87-94. PubMed ID: 26253248
[TBL] [Abstract][Full Text] [Related]
25. Serum BAFF levels and skin mRNA expression in patients with Behçet's disease.
Hamzaoui K; Houman H; Ben Dhifallah I; Kamoun M; Hamzaoui A
Clin Exp Rheumatol; 2008; 26(4 Suppl 50):S64-71. PubMed ID: 19026118
[TBL] [Abstract][Full Text] [Related]
26. Effect of Interferon alfa-2a Treatment on Adaptive and Innate Immune Systems in Patients With Behçet Disease Uveitis.
Albayrak O; Oray M; Can F; Uludag Kirimli G; Gul A; Tugal-Tutkun I; Onal S
Invest Ophthalmol Vis Sci; 2019 Jan; 60(1):52-63. PubMed ID: 30601931
[TBL] [Abstract][Full Text] [Related]
27. Altered Expression of Specific Transcription Factors of Th17 (RORγt, RORα) and Treg Lymphocytes (FOXP3) by Peripheral Blood Mononuclear Cells from Patients with Multiple Sclerosis.
Etesam Z; Nemati M; Ebrahimizadeh MA; Ebrahimi HA; Hajghani H; Khalili T; Frootan R; Zinoddini N; Jafarzadeh A
J Mol Neurosci; 2016 Sep; 60(1):94-101. PubMed ID: 27370539
[TBL] [Abstract][Full Text] [Related]
28. Upregulated IL-1 Receptor-associated Kinase 1 (IRAK1) in Systemic Lupus Erythematosus: IRAK1 Inhibition Represses Th17 Differentiation with Therapeutic Potential.
Zhou Z; Tian Z; Zhang M; Zhang Y; Ni B; Hao F
Immunol Invest; 2018 Jul; 47(5):468-483. PubMed ID: 29611775
[TBL] [Abstract][Full Text] [Related]
29. Inhibition of Th17 differentiation by anti-TNF-alpha therapy in uveitis patients with Behçet's disease.
Sugita S; Kawazoe Y; Imai A; Yamada Y; Horie S; Mochizuki M
Arthritis Res Ther; 2012 May; 14(3):R99. PubMed ID: 22546542
[TBL] [Abstract][Full Text] [Related]
30. Interleukin-28A promotes IFN-γ production by peripheral blood mononuclear cells from patients with Behçet's disease.
Li B; Xie C; Lin X; Su SB
Cell Immunol; 2014 Jul; 290(1):116-9. PubMed ID: 24973639
[TBL] [Abstract][Full Text] [Related]
31. Imbalance of Peripheral Blood T Helper Type 17 Responses in Patients with Vitiligo.
Behfarjam F; Mansouri P; Jadali Z
Iran J Allergy Asthma Immunol; 2018 Apr; 17(2):171-178. PubMed ID: 29757590
[TBL] [Abstract][Full Text] [Related]
32. MicroRNA-155 regulates the Th17 immune response by targeting Ets-1 in Behçet's disease.
Na SY; Park MJ; Park S; Lee ES
Clin Exp Rheumatol; 2016; 34(6 Suppl 102):S56-S63. PubMed ID: 27156371
[TBL] [Abstract][Full Text] [Related]
33. Inflammatory status might direct ILC and NK cells to IL-17 expressing ILC3 and NK subsets in Behcet's disease.
Gelmez MY; Cinar S; Cetin EA; Ozcit-Gürel G; Babuna-Kobaner G; Erdugan M; Gul A; Akdag-Kose A; Deniz G
Immunol Lett; 2021 Jul; 235():1-8. PubMed ID: 33901541
[TBL] [Abstract][Full Text] [Related]
34. Effect of γ-secretase inhibitor on Th17 cell differentiation and function of mouse psoriasis-like skin inflammation.
Ma L; Xue H; Qi R; Wang Y; Yuan L
J Transl Med; 2018 Mar; 16(1):59. PubMed ID: 29523162
[TBL] [Abstract][Full Text] [Related]
35. Increased levels of Th17 cells are associated with non-neuronal acetylcholine in COPD patients.
Profita M; Albano GD; Riccobono L; Di Sano C; Montalbano AM; Gagliardo R; Anzalone G; Bonanno A; Pieper MP; Gjomarkaj M
Immunobiology; 2014 May; 219(5):392-401. PubMed ID: 24529390
[TBL] [Abstract][Full Text] [Related]
36. Increased circulating Th17 cell populations and elevated CSF osteopontin and IL-17 concentrations in patients with Guillain-Barré syndrome.
Han RK; Cheng YF; Zhou SS; Guo H; He RD; Chi LJ; Zhang LM
J Clin Immunol; 2014 Jan; 34(1):94-103. PubMed ID: 24217817
[TBL] [Abstract][Full Text] [Related]
37. Critical regulation of Th17 cell differentiation by serum amyloid-A signalling in Behcet's disease.
Lucherini OM; Lopalco G; Cantarini L; Emmi G; Lopalco A; Venerito V; Vitale A; Iannone F
Immunol Lett; 2018 Sep; 201():38-44. PubMed ID: 30385329
[TBL] [Abstract][Full Text] [Related]
38. IRF4 regulates IL-17A promoter activity and controls RORγt-dependent Th17 colitis in vivo.
Mudter J; Yu J; Zufferey C; Brüstle A; Wirtz S; Weigmann B; Hoffman A; Schenk M; Galle PR; Lehr HA; Mueller C; Lohoff M; Neurath MF
Inflamm Bowel Dis; 2011 Jun; 17(6):1343-58. PubMed ID: 21305677
[TBL] [Abstract][Full Text] [Related]
39. [Efficacy and safety of metformin for Behcet's disease and its effect on Treg/Th17 balance: a single-blinded, before-after study].
Yong C; Dan L; Chenhong L; Yan S; Jianfei C; Jianlong G
Nan Fang Yi Ke Da Xue Xue Bao; 2019 Feb; 39(2):127-133. PubMed ID: 30890498
[TBL] [Abstract][Full Text] [Related]
40. p300 promotes differentiation of Th17 cells via positive regulation of the nuclear transcription factor RORγt in acute respiratory distress syndrome.
Chen Y; Wang D; Zhao Y; Huang B; Cao H; Qi D
Immunol Lett; 2018 Oct; 202():8-15. PubMed ID: 30009847
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
